Researchers at the University of Nevada, Las Vegas disclosed an innovative mRNA delivery technique enabling organ-specific targeting of the pancreas, offering promising applications in treating diabetes and pancreatic cancer. Published in Advanced Materials, this approach exploits endogenous biological pathways to improve delivery precision and reduce off-target effects, representing a potential paradigm shift in RNA-based therapeutics for pancreatic diseases.